{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:18:09Z","timestamp":1771082289921,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008397","name":"Velux Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jgo.2019.12.005","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T18:42:51Z","timestamp":1577385771000},"page":"593-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The influence of polypharmacy, potentially inappropriate medications, and drug interactions on treatment completion and prognosis in older patients with ovarian cancer"],"prefix":"10.1016","volume":"11","author":[{"given":"Trine Lembrecht","family":"J\u00f8rgensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rn","family":"Herrstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2019.12.005_bb0005","author":"Engholm"},{"key":"10.1016\/j.jgo.2019.12.005_bb0010","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2019.12.005_bb0015","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"Lewis","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0020","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1200\/JCO.2012.41.6727","article-title":"Under-representation of older adults in cancer registration trials: known problem, little progress","volume":"30","author":"Scher","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jgo.2011.09.001","article-title":"Polypharmacy and drug use in elderly Danish cancer patients during 1996 to 2006","volume":"3","author":"Jorgensen","year":"2012","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jgo.2016.07.010","article-title":"Polypharmacy and potentially inappropriate medication use in geriatric oncology","volume":"7","author":"Sharma","year":"2016","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ygyno.2016.01.012","article-title":"The influence of polypharmacy on grade III\/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer","volume":"140","author":"Woopen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016358","article-title":"Association between polypharmacy and falls in older adults: a longitudinal study from England","volume":"7","author":"Dhalwani","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jgo.2019.12.005_bb0045","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/jgs.14718","article-title":"Is polypharmacy associated with frailty in older people? Results from the ESTHER cohort study","volume":"65","author":"Saum","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2019.12.005_bb0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jso.23369","article-title":"Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery","volume":"108","author":"Badgwell","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0055","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.leukres.2014.06.018","article-title":"The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML)","volume":"38","author":"Elliot","year":"2014","journal-title":"Leuk Res"},{"key":"10.1016\/j.jgo.2019.12.005_bb0060","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/jgs.12942","article-title":"Polypharmacy and potentially inappropriate medication use among older adults with cancer undergoing chemotherapy: impact on chemotherapy-related toxicity and hospitalization during treatment","volume":"62","author":"Maggiore","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2019.12.005_bb0065","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00432-015-2108-x","article-title":"Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer","volume":"142","author":"Park","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0070","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2019.12.005_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.jgo.2019.12.005_bb0080","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0895-4356(94)90192-9","article-title":"A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity","volume":"47","author":"Samsa","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0085","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries","volume":"71","author":"Renom-Guiteras","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jgo.2012.02.005","article-title":"Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer","volume":"3","author":"Prithviraj","year":"2012","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jgo.2014.07.001","article-title":"Potentially inappropriate medication use in older people with cancer: prevalence and correlates","volume":"5","author":"Saarelainen","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2014.58.7550","article-title":"Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer","volume":"33","author":"Nightingale","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jgo.2016.05.001","article-title":"Drugs prescribed for patients hospitalized in a geriatric oncology unit: potentially inappropriate medications and impact of a clinical pharmacist","volume":"7","author":"Deliens","year":"2016","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0110","first-page":"229","article-title":"Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients","volume":"25","author":"Alkan","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0115","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"1","article-title":"Pharmacokinetics and pharmacodynamics","author":"Buxton","year":"2006"},{"key":"10.1016\/j.jgo.2019.12.005_bb0120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.critrevonc.2010.05.004","article-title":"Potential drug interactions in elderly cancer patients","volume":"78","author":"Girre","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jgo.2014.04.002","article-title":"Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy","volume":"5","author":"Popa","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/cpt.674","article-title":"Clopidogrel-paclitaxel drug-drug interaction: a pharmacoepidemiologic study","volume":"102","author":"Agergaard","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jgo.2019.12.005_bb0135","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/bjc.2015.120","article-title":"The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people","volume":"112","author":"Kalsi","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/00016340902846064","article-title":"Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish gynecological cancer database","volume":"88","author":"Petri","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jgo.2019.12.005_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jgo.2019.12.005_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002280050329","article-title":"Methods for estimating the occurrence of polypharmacy by means of a prescription database","volume":"53","author":"Bjerrum","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0165","series-title":"Carboplatin, paclitaxel. Lexicomp\u00ae","year":"2019"},{"key":"10.1016\/j.jgo.2019.12.005_bb0175","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/bjc.2012.46","article-title":"Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality","volume":"106","author":"Jorgensen","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.breast.2013.11.004","article-title":"Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group","volume":"23","author":"Hamaker","year":"2014","journal-title":"Breast (Edinburgh, Scotland)"},{"key":"10.1016\/j.jgo.2019.12.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1177\/1078155218788698","article-title":"Evaluation of potentially inappropriate medication utilization in elderly patients with cancer at outpatient oncology unit","author":"Paksoy","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jgo.2019.12.005_bb0190","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/pon.3886","article-title":"Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA cohort study","volume":"25","author":"Canoui-Poitrine","year":"2016","journal-title":"Psycho-oncology"},{"key":"10.1016\/j.jgo.2019.12.005_bb0195","first-page":"1727","article-title":"Prevalence and factors associated with polypharmacy in older people with cancer","volume":"22","author":"Turner","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0200","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1002\/cncr.27427","article-title":"Use of complementary medications among older adults with cancer","volume":"118","author":"Maggiore","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0205","first-page":"1831","article-title":"Polypharmacy cut-points in older people with cancer: how many medications are too many?","volume":"24","author":"Turner","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0210","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/cncr.28184","article-title":"Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status","volume":"119","author":"de Glas","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0215","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00228-018-2534-1","article-title":"The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large cohort study","volume":"74","author":"Muhlack","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0220","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00228-017-2246-y","article-title":"Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol","volume":"73","author":"Mucalo","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0225","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.sapharm.2018.06.002","article-title":"Factors associated with the use of potentially inappropriate medications by older adults in primary health care: An analysis comparing AGS Beers, EU(7)-PIM List, and Brazilian Consensus PIM criteria","volume":"15","author":"Almeida","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.jgo.2019.12.005_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jcpt.12494","article-title":"The use of potentially inappropriate medications among the Lithuanian elderly according to beers and EU(7)-PIM list - a nationwide cross-sectional study on reimbursement claims data","volume":"42","author":"Grina","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jgo.2019.12.005_bb0235","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/ggi.12944","article-title":"Comparison of four criteria for potentially inappropriate medications in Brazilian community-dwelling older adults","volume":"17","author":"Novaes","year":"2017","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jgo.2019.12.005_bb0240","first-page":"1313","article-title":"Use of unnecessary medications by patients with advanced cancer: cross-sectional survey","volume":"19","author":"Fede","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amjopharm.2009.05.002","article-title":"Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit","volume":"7","author":"Flood","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jgo.2019.12.005_bb0250","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/cncr.31403","article-title":"Potentially inappropriate medication use in older patients with breast and colorectal cancer","volume":"124","author":"Karuturi","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2019.12.005_bb0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jgo.2017.07.015","article-title":"Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: observational single-center study of 122 patients","volume":"9","author":"Leger","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bjh.15027","article-title":"Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities","volume":"180","author":"Lin","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0265","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jgo.2017.05.003","article-title":"Factors associated with the use of potentially inappropriate medications by older adults with cancer","volume":"8","author":"Reis","year":"2017","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2019.12.005_bb0270","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jgo.2018.02.001","article-title":"The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software","volume":"9","author":"Nightingale","year":"2018","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2019.12.005_bb0275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1055-9965.EPI-17-0523","article-title":"Potential medication-related problems in older breast, colon, and lung cancer patients in the United States","volume":"27","author":"Lund","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jgo.2019.12.005_bb0280","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406819302930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406819302930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:52:12Z","timestamp":1761817932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406819302930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1879406819302930"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2019.12.005","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of polypharmacy, potentially inappropriate medications, and drug interactions on treatment completion and prognosis in older patients with ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}